ISENTRESS
Generic: RALTEGRAVIR
Merck Sharp & Dohme LLCManufacturer
ORALRoute
RALTEGRAVIR POTASSIUMActive Substance
2007-10-12Original Approval
ISENTRESS is FDA application NDA022145, sponsored by MSD SUB MERCK. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INTERACTION
1,210 reports
2
FOETAL EXPOSURE DURING PREGNANCY
1,078 reports
3
DEPRESSION
1,017 reports
4
ANXIETY
966 reports
5
PAIN
917 reports
6
EMOTIONAL DISTRESS
789 reports
7
EXPOSURE DURING PREGNANCY
742 reports
8
MATERNAL EXPOSURE DURING PREGNANCY
742 reports
9
ANHEDONIA
708 reports
10
VIROLOGIC FAILURE
587 reports